Literature DB >> 19483048

Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension.

L E R McLure1, A J Peacock.   

Abstract

Pulmonary hypertension is a disease of the pulmonary arteries resulting in a progressive increase in pulmonary vascular resistance, ultimately leading to right ventricular failure and death. The functional capacity of the right ventricle is a major prognostic determinant. Our understanding of right ventricle performance in pulmonary hypertension has been hindered by the lack of techniques that give a reliable picture of right ventricle morphology and function. Cardiac magnetic resonance (CMR) imaging enables a unique combination of morphological and functional assessment of the right ventricle and pulmonary circulation. In this review article, we introduce the technique of CMR imaging, review its use in imaging of the heart and pulmonary circulation and discuss its current and future application to the management of patients with pulmonary hypertension. There have been recent major advances in our understanding of the mechanism of disease development, in the diagnostic process, and in the treatment of pulmonary hypertension. Therapeutic advances in the management have reinforced the requirement for noninvasive, accurate and reproducible methods of assessment to act as "end-points" to measure the effects of treatment. We anticipate CMR imaging will increasingly be utilised as the primary modality for combined anatomic and functional assessments that enable more complete and efficient evaluation of pulmonary hypertension patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483048     DOI: 10.1183/09031936.00139907

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  26 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 2.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Authors:  Theodoros Dimitroulas; Sophie Mavrogeni; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

3.  Simple prediction of right ventricular ejection fraction using tricuspid annular plane systolic excursion in pulmonary hypertension.

Authors:  Takahiro Sato; Ichizo Tsujino; Noriko Oyama-Manabe; Hiroshi Ohira; Yoichi M Ito; Hiroyuki Sugimori; Asuka Yamada; Chisa Takashina; Taku Watanabe; Masaharu Nishimura
Journal:  Int J Cardiovasc Imaging       Date:  2013-09-04       Impact factor: 2.357

4.  Early detection of pulmonary arterial hypertension: do not forget the right ventricle.

Authors:  Gaetano Ruocco; Alberto Palazzuoli
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

5.  Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension.

Authors:  Sebastian Ley; Christian Fink; Frank Risse; Nicola Ehlken; Christine Fischer; Julia Ley-Zaporozhan; Hans-Ulrich Kauczor; Hans Klose; Ekkehard Gruenig
Journal:  Eur Radiol       Date:  2012-08-12       Impact factor: 5.315

Review 6.  Assessment and treatment of right ventricular failure.

Authors:  Marc A Simon
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

7.  Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.

Authors:  J Michael Wells; Anand S Iyer; Farbod N Rahaghi; Surya P Bhatt; Himanshu Gupta; Thomas S Denney; Steven G Lloyd; Louis J Dell'Italia; Hrudaya Nath; Raul San Jose Estepar; George R Washko; Mark T Dransfield
Journal:  Circ Cardiovasc Imaging       Date:  2015-04       Impact factor: 7.792

8.  Multiparametric Magnetic Resonance Imaging in the Assessment of Pulmonary Hypertension: Initial Experience of a One-Stop Study.

Authors:  Gisela M B Meyer; Fernanda B Spilimbergo; Stephan Altmayer; Gabriel S Pacini; Matheus Zanon; Guilherme Watte; Edson Marchiori; Bruno Hochhegger
Journal:  Lung       Date:  2018-02-12       Impact factor: 2.584

9.  The value of hepatic diffusion-weighted MR imaging in demonstrating hepatic congestion secondary to pulmonary hypertension.

Authors:  Yuksel Dogan; Aliye Soylu; Ozgur Kilickesmez; Tuna Demirtas; Kadriye Orta Kilickesmez; Sebahat Nacar Dogan; Gulay Eren; Isa Sevindir; Nurgul Yasar; Sule Poturoglu; Kenan Sonmez
Journal:  Cardiovasc Ultrasound       Date:  2010-07-21       Impact factor: 2.062

10.  The strain-encoded (SENC) MR imaging for detection of global right ventricular dysfunction in pulmonary hypertension.

Authors:  Noriko Oyama-Manabe; Takahiro Sato; Ichizo Tsujino; Kohsuke Kudo; Osamu Manabe; Fumi Kato; Nael F Osman; Satoshi Terae
Journal:  Int J Cardiovasc Imaging       Date:  2012-08-03       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.